Novel Approaches in Cancer Study( NACS ISSN: 2637-773X, Impact Factor:0.637)

  Aptamer Technology in the Targeted Delivery of Doxorubicin- Crimson Publishers                                                     

                                                     

Aptamer Technology in the Targeted Delivery of Doxorubicin by Duaa Dakhlallah in Novel  Approaches in Cancer Study

This review aims at giving an insight at some of the recent approaches in using the aptamer technology in formulating the chemotherapeutic agent, doxorubicin, so as to achieve its targeted delivery and reduce its non-specific cytotoxicity.

https://crimsonpublishers.com/nacs/fulltext/NACS.000502.php